KR870001693B1 - 1,4-디하이드로-4-옥소나프티리딘 유도체의 제조방법 - Google Patents

1,4-디하이드로-4-옥소나프티리딘 유도체의 제조방법 Download PDF

Info

Publication number
KR870001693B1
KR870001693B1 KR1019850002822A KR850002822A KR870001693B1 KR 870001693 B1 KR870001693 B1 KR 870001693B1 KR 1019850002822 A KR1019850002822 A KR 1019850002822A KR 850002822 A KR850002822 A KR 850002822A KR 870001693 B1 KR870001693 B1 KR 870001693B1
Authority
KR
South Korea
Prior art keywords
group
dihydro
oxo
salt
compound
Prior art date
Application number
KR1019850002822A
Other languages
English (en)
Korean (ko)
Other versions
KR850007596A (ko
Inventor
히로가주 나리따
요시노리 고니시
준 니따
히데요시 나가끼
이사오 기따야마
요리꼬 고바야시
미가꼬 시나가와
야수오 와따나베
아끼라 요쭈지
신자부로 미나미
이사무 사이가와
Original Assignee
도야마 가가꾸 고오교오 가부시끼 가이샤
나까노 다다오
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=13845280&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=KR870001693(B1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by 도야마 가가꾸 고오교오 가부시끼 가이샤, 나까노 다다오 filed Critical 도야마 가가꾸 고오교오 가부시끼 가이샤
Publication of KR850007596A publication Critical patent/KR850007596A/ko
Application granted granted Critical
Publication of KR870001693B1 publication Critical patent/KR870001693B1/ko

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/61—Halogen atoms or nitro radicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/72—Nitrogen atoms
    • C07D213/74—Amino or imino radicals substituted by hydrocarbon or substituted hydrocarbon radicals
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups
KR1019850002822A 1984-04-26 1985-04-25 1,4-디하이드로-4-옥소나프티리딘 유도체의 제조방법 KR870001693B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JP84963 1984-04-26
JP84963/84 1984-04-26
JP59084963A JPS60228479A (ja) 1984-04-26 1984-04-26 １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩

Publications (2)

Publication Number Publication Date
KR850007596A KR850007596A (ko) 1985-12-07
KR870001693B1 true KR870001693B1 (ko) 1987-09-24

Family

ID=13845280

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1019850002822A KR870001693B1 (ko) 1984-04-26 1985-04-25 1,4-디하이드로-4-옥소나프티리딘 유도체의 제조방법

Country Status (30)

Country Link
JP (1) JPS60228479A (ja)
KR (1) KR870001693B1 (ja)
AR (1) AR241911A1 (ja)
AT (2) AT389698B (ja)
AU (2) AU565087B2 (ja)
BE (1) BE902279A (ja)
CH (1) CH673458A5 (ja)
CS (1) CS250684B2 (ja)
DD (1) DD238795A5 (ja)
DE (2) DE3514076A1 (ja)
DK (1) DK165877C (ja)
EG (1) EG17339A (ja)
ES (2) ES8700256A1 (ja)
FI (1) FI80453C (ja)
FR (2) FR2563521B1 (ja)
GB (2) GB2158825B (ja)
HU (2) HU197571B (ja)
ID (1) ID21142A (ja)
IL (1) IL75021A (ja)
IT (1) IT1209953B (ja)
LU (1) LU85871A1 (ja)
NL (2) NL187314C (ja)
NO (1) NO162238C (ja)
NZ (1) NZ211895A (ja)
PH (3) PH22801A (ja)
PL (1) PL147392B1 (ja)
PT (1) PT80349B (ja)
RO (2) RO95509B (ja)
SE (2) SE463102B (ja)
ZA (1) ZA853102B (ja)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100981351B1 (ko) * 2003-10-29 2010-09-10 주식회사 엘지생명과학 7-클로로-1-사이클로프로필-6-플루오로-4-옥소-1,4-디하이드로-1,8-나프티리딘-3-카복실산의 제조방법

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS6172753A (ja) * 1984-09-18 1986-04-14 Dainippon Pharmaceut Co Ltd ピリジルケトン誘導体
AU576657B2 (en) * 1985-01-23 1988-09-01 Toyama Chemical Co. Ltd. Naphthyridine and pyridine derivatives
AT392789B (de) * 1985-01-23 1991-06-10 Toyama Chemical Co Ltd Verfahren zur herstellung von 1-substituierten aryl-1,4-dihydro-4-oxonaphthyridinderivaten
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester
ATE75740T1 (de) * 1985-06-26 1992-05-15 Daiichi Seiyaku Co Pyridoncarbonsaeurederivate.
US4962112A (en) * 1987-08-04 1990-10-09 Abbott Laboratories 7-(2-methyl-4-aminopyrrolidinyl)naphthryidine and quinoline compounds
IE62600B1 (en) * 1987-08-04 1995-02-22 Abbott Lab Naphtyridine antianaerobic compounds
US4859776A (en) * 1988-03-11 1989-08-22 Abbott Laboratories (S)-7-(3-aminopyrrolidin-1-yl)-1-(ortho, para-difluorophenyl)-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid and method for its preparation
JP2844079B2 (ja) * 1988-05-23 1999-01-06 塩野義製薬株式会社 ピリドンカルボン酸系抗菌剤
DE3934082A1 (de) * 1989-10-12 1991-04-18 Bayer Ag Chinoloncarbonsaeurederivate, verfahren zu ihrer herstellung sowie ihre verwendung als antivirale mittel
AU1161492A (en) * 1991-01-14 1992-08-17 Hanmi Pharmaceutical Co., Ltd. Novel quinolone compounds and processes for preparation thereof
FR2692577B1 (fr) * 1992-05-26 1996-02-02 Bouchara Sa Nouvelles quinolones fluorees, leur procede de preparation et les compositions pharmaceutiques en renfermant.
KR940014395A (ko) * 1992-12-09 1994-07-18 강박광 신규한 퀴놀론 유도체 및 그의 제조방법
KR0148277B1 (ko) * 1993-01-18 1998-11-02 채영복 신규한 플루오르퀴놀론계 유도체 및 그의 제조방법
AU4272793A (en) * 1993-04-24 1994-11-21 Korea Research Institute Of Chemical Technology Novel quinolone carboxylic acid derivatives and process for preparing the same
KR950018003A (ko) * 1993-12-09 1995-07-22 스미스클라인 비참 피엘씨 신규한 퀴놀론 유도체 및 그의 제조 방법
DE69531305T2 (de) * 1994-10-20 2004-05-13 Wakunaga Seiyaku K.K. Pyridoncarboxylat- derivate oder salze davon und antibakterielle zusammensetzungen die diese als aktiven bestandteil enthalten
WO1997040036A1 (fr) 1996-04-19 1997-10-30 Wakunaga Pharmaceutical Co., Ltd. Nouveaux derives de l'acide pyridonocarboxylique ou des sels de cet acide et agents antibacteriens contenant ces substances en tant que composant actif
KR20000052892A (ko) * 1996-10-30 2000-08-25 빌프리더 하이더 나프티리딘 화합물의 제조 방법 및 신규 중간 생성물
DE19713506A1 (de) 1997-04-01 1998-10-08 Bayer Ag Verfahren zur Herstellung von 2,6-Dichlor-5-fluornicotinonitril und die chemische Verbindung 3-Cyano-2-hydroxy-5-fluorpyrid-6-on-mononatriumsalz sowie dessen Tautomere
KR100768034B1 (ko) 1999-03-17 2007-10-17 다이이찌 세이야꾸 가부시기가이샤 의약 조성물
US6441182B1 (en) 1999-06-10 2002-08-27 Bayer Aktiengesellschaft Method for the production of 2,6-dichloro-5-fluoro-nicotinic acid and coarse and particularly pure 2,6-dichloro-5-fluoro-nicotinic acid
WO2001017991A1 (fr) 1999-09-02 2001-03-15 Wakunaga Pharmaceutical Co., Ltd. Derive d'acide quinolinecarboxylique ou son sel
EP1313708A1 (en) * 2000-08-29 2003-05-28 Chiron Corporation Quinoline antibacterial compounds and methods of use thereof
CN101792443A (zh) * 2010-03-09 2010-08-04 北京欧凯纳斯科技有限公司 氟代喹诺酮衍生物及其制备方法和用途
JOP20190045A1 (ar) 2016-09-14 2019-03-14 Bayer Ag مركبات أميد حمض 1- أريل-نفثيريدين-3-كربوكسيليك مستبدلة في الموضع 7 واستخدامها.
CN114369092A (zh) * 2021-12-20 2022-04-19 赤峰万泽药业股份有限公司 甲苯磺酸妥舒沙星及其制备方法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2125310A1 (en) * 1971-05-21 1972-11-30 Sterling Drug Inc , New York, NY (V St A) 1-alkyl-1,4-dihydro-4-oxo-1,8-naphtyridine 3-carboxylic acids antibac
AR223983A1 (es) * 1978-08-25 1981-10-15 Dainippon Pharmaceutical Co Un procedimiento para-preparar derivados de acido 6-halogeno-4-oxo-7-(1-piperazinil)-1,8-naftiridin-3-carboxilico
DE3033157A1 (de) * 1980-09-03 1982-04-01 Bayer Ag, 5090 Leverkusen 7-amino-1-cyclopropyl-4-oxo-1,4-dihydro-naphthyridin-3-carbonsaeuren, verfahren zu ihrer herstellung sowie diese enthaltende antibakterielle mittel
US4382937A (en) * 1981-02-27 1983-05-10 Dainippon Pharmaceutical Co., Ltd. Naphthyridine derivatives and their use as anti-bacterials
IE55898B1 (en) * 1982-09-09 1991-02-14 Warner Lambert Co Antibacterial agents
NZ210847A (en) * 1984-01-26 1988-02-29 Abbott Lab Naphthyridine and pyridopyrimidine derivatives and pharmaceutical compositions
IL74064A (en) * 1984-01-26 1988-09-30 Abbott Lab 1,7-disubstituted-1,4-dihydro-6-fluoro-4-oxo-1,8-naphthyridine-3-carboxylic acid derivatives and antibacterial compositions containing them
AU576657B2 (en) * 1985-01-23 1988-09-01 Toyama Chemical Co. Ltd. Naphthyridine and pyridine derivatives
DE3525108A1 (de) * 1985-06-07 1986-12-11 Bayer Ag, 5090 Leverkusen Antibakteriell wirksame chinoloncarbonsaeureester

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100981351B1 (ko) * 2003-10-29 2010-09-10 주식회사 엘지생명과학 7-클로로-1-사이클로프로필-6-플루오로-4-옥소-1,4-디하이드로-1,8-나프티리딘-3-카복실산의 제조방법

Also Published As

Publication number Publication date
RO91871B (ro) 1987-07-31
ATA267888A (de) 1989-09-15
GB8510297D0 (en) 1985-05-30
CH673458A5 (ja) 1990-03-15
PH25046A (en) 1991-01-28
FR2563521A1 (fr) 1985-10-31
DK185685D0 (da) 1985-04-25
CS250684B2 (en) 1987-05-14
NO162238C (no) 1989-12-06
ES542584A0 (es) 1986-09-16
GB2158825A (en) 1985-11-20
IT1209953B (it) 1989-08-30
AU612993B2 (en) 1991-07-25
PT80349B (pt) 1987-09-30
IT8548002A0 (it) 1985-04-26
DE3514076A1 (de) 1985-10-31
SE463102B (sv) 1990-10-08
FR2614620A1 (fr) 1988-11-04
FI851637A0 (fi) 1985-04-25
ES8706673A1 (es) 1987-07-01
GB2191776A (en) 1987-12-23
PL253108A1 (en) 1985-12-17
NZ211895A (en) 1988-07-28
IL75021A0 (en) 1985-08-30
HUT38634A (en) 1986-06-30
AT389698B (de) 1990-01-10
SE8804586L (sv) 1988-12-20
KR850007596A (ko) 1985-12-07
DK165877C (da) 1993-06-21
FI80453C (fi) 1990-06-11
IL75021A (en) 1994-01-25
SE8502017D0 (sv) 1985-04-25
RO91871A (ro) 1987-07-30
AU8180487A (en) 1988-03-24
FR2614620B1 (fr) 1990-03-09
GB2191776B (en) 1990-03-28
BE902279A (fr) 1985-10-25
GB8716897D0 (en) 1987-08-26
NL187314C (nl) 1991-08-16
DE3514076C2 (ja) 1989-03-30
DK185685A (da) 1985-10-27
SE8502017L (sv) 1985-10-27
AT390258B (de) 1990-04-10
FI80453B (fi) 1990-02-28
SE8804586D0 (sv) 1988-12-20
PH25228A (en) 1991-03-27
RO95509A (ro) 1988-09-30
ID21142A (id) 1999-04-29
AU565087B2 (en) 1987-09-03
RO95509B (ro) 1988-10-01
DD238795A5 (de) 1986-09-03
PL147392B1 (en) 1989-05-31
AR241911A1 (es) 1993-01-29
NO851643L (no) 1985-10-28
PT80349A (en) 1985-05-01
DK165877B (da) 1993-02-01
PH22801A (en) 1988-12-12
FI851637L (fi) 1985-10-27
JPS6320828B2 (ja) 1988-04-30
SE501412C2 (sv) 1995-02-13
HU197571B (en) 1989-04-28
ES8700256A1 (es) 1986-09-16
EG17339A (en) 1989-06-30
NL9100648A (nl) 1991-08-01
NO162238B (no) 1989-08-21
ZA853102B (en) 1986-12-30
LU85871A1 (en) 1985-12-16
GB2158825B (en) 1989-01-25
ES551538A0 (es) 1987-07-01
JPS60228479A (ja) 1985-11-13
FR2563521B1 (fr) 1989-02-03
AU4165085A (en) 1985-10-31
HU194226B (en) 1988-01-28
NL8501172A (nl) 1985-11-18
ATA122485A (de) 1989-06-15
DE3546658C2 (ja) 1992-04-02

Similar Documents

Publication Publication Date Title
KR870001693B1 (ko) 1,4-디하이드로-4-옥소나프티리딘 유도체의 제조방법
NO161370B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin- og naftyridin-derivater.
EP0255908B1 (en) 7-[[3-(aminomethyl)-3-alkyl]-1-pyrrolidinyl]-quinoline-carboxylic acid-derivatives and pharmaceutical compositions containing them
US6136823A (en) Pyridonecarboxylic acid derivatives or salts thereof and drugs containing the same as the active ingredient
NO312032B1 (no) Nye kinolon- eller naftylidonkarboksylsyre-derivater eller salter derav samt anvendelse derav
IE54898B1 (en) New quinolone compounds and preparation thereof
JPS61243077A (ja) 抗菌剤
NO162721B (no) Analogifremgangsmaate for fremstilling av terapeutisk aktive kinolin- og naftyridinderivater.
EP0160284B1 (en) Quino-benoxazine antibacterial compounds
JPS6233176A (ja) １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩
JPH01139583A (ja) 抗菌薬として有用な４−オキソ−３−キノリンカルボン酸およびその製法
EP0162333B1 (en) Quino-benzothiazine antibacterial compounds
JP2704428B2 (ja) キノロンカルボン酸誘導体またはその塩
US4720495A (en) Benzo[ij]quinolizine-2-carboxylic acids useful for treating bacterial infection
JP2598921B2 (ja) 新規なキノリン誘導体およびその塩
US5631266A (en) Quinolone carboxylic acid derivatives and process for preparing the same
KR970001159B1 (ko) 신규 1,8-나프티리딘 유도체 및 그의 제조방법
JPS6270370A (ja) キノロンカルボン酸誘導体およびその製造方法
JPS6237006B2 (ja)
JPH07300472A (ja) 新規キノロンカルボン酸誘導体およびその製造方法
JPH03181478A (ja) ピリドンカルボン酸誘導体
KR920003689B1 (ko) 퀴놀론카르복실산 유도체 및 그의 제조방법
JP2630566B2 (ja) １，４−ジヒドロー４−オキソナフチリジン誘導体またはその塩
JPS6284085A (ja) １，４―ジヒドロ―４―オキソナフチリジン誘導体またはその塩
JPH0633262B2 (ja) １，４−ジヒドロ−４−オキソナフチリジン誘導体およびその塩

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
G160 Decision to publish patent application
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20040910

Year of fee payment: 18

EXPY Expiration of term